OIG Recommends CMS Improve Naloxone Access for Medicaid Beneficiaries
The opioid crisis continues to devastate communities across the United States, with overdose deaths reaching record highs in recent years. Naloxone, a medication that...
Medicaid Expansion Leads to Spike in Number of People Receiving SUD Treatment
The expansion of Medicaid under the Affordable Care Act (ACA) has had a significant impact on access to care for individuals struggling with substance...
The Changing Landscape of Medicaid Reimbursement for Psychiatric Care: The IMD Waiver Debate
For decades, the federal government has restricted Medicaid from covering the cost of inpatient psychiatric care for patients in facilities with more than 16...
Medicaid Work Requirements: A Threat to Behavioral Health Providers Nationwide
Despite significant opposition from federal courts, advocates, and behavioral health providers, the push for Medicaid work requirements continues to gain traction across the United...
The IMD Exclusion and the Changing Landscape of Medicaid Reimbursement for Mental Health Treatment
For many years, federal rules restricted Medicaid from reimbursing the costs of inpatient psychiatric care for patients in facilities with more than 16 beds,...
CMS Expands Medicaid Coverage for Opioid Use Disorder Treatment
The Centers for Medicare & Medicaid Services (CMS) has taken a significant step in addressing the opioid crisis by expanding coverage for Medicaid beneficiaries...
